Accueil › Cancer du poumon › Missouri › St. Louis
Essais cliniques pour Cancer du poumon à St. Louis, MO
39 études pour Cancer du poumon recherchent des participants dans et autour de St. Louis (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
The Vanguard Study: Testing a New Way to Screen for Cancer
Recrutement en coursVolontaires sains bienvenus
- Washington University School of Medicine, St Louis
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Recrutement en coursPhase 3
- Mercy Hospital South, St Louis
- Cancer Care Center of O'Fallon, O'Fallon · à 16 mi
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Recrutement en coursPhase 3
- Washington University School of Medicine, St Louis
- Veteran's Affairs Medical Center - Saint Louis, St Louis
- Mercy Hospital South, St Louis
- et 7 autres
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Recrutement en coursPhase 3
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- Mercy Hospital Saint Louis, St Louis
- et 1 autres
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Recrutement en coursÉtude observationnelleVolontaires sains bienvenus
- Mercy Infusion Center - Chippewa, St Louis
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- et 4 autres
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Recrutement en coursPhase 2
- Washington University, School of Medicine, St Louis
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Recrutement en coursPhase 3
- Mercy Hospital South, St Louis
- Mercy Hospital Saint Louis, St Louis
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Recrutement en coursPhase 1
- Washington University School of Medicine, St Louis
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Recrutement en coursPhase 3
- Washington University Center for Advanced Medicine, St Louis
A Study of PHN-012 in Patients With Advanced Solid Tumors
Recrutement en coursPhase 1
- PHN-012-001 Site, St Louis
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Recrutement en coursPhase 3
- Washington University School of Medicine - Siteman Cancer Center, St Louis
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Recrutement en coursPhase 3
- Mercy South - David M Sindelar Cancer Center ( Site 0098), St Louis
- Mercy Research - David C. Pratt Cancer Center ( Site 0006), St Louis
A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
Recrutement en coursPhase 2
- Washington University School of Medicine, St Louis
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
Recrutement en coursPhase 1/2
- Local Institution - 0140, St Louis
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Recrutement en coursPhase 2/3
- SSM Health Cancer Care - St. Clare, Fenton · à 15 mi
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
Recrutement en coursPhase 2/3
- Washington University School of Medicine, St Louis
A Study Evaluating a New Radiation Treatment Workflow (NGDS)
Recrutement en cours
- Siteman Cancer Center Washington University, St Louis
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Recrutement en coursPhase 1/2
- Washington University, St Louis
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Recrutement en coursPhase 3
- Missouri Baptist Medical Center, St Louis
Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
Recrutement en coursÉtude observationnelle
- Washington University School of Medicine, St Louis
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
Recrutement en coursPhase 3
- Washington University School of Medicine, St Louis
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Recrutement en coursPhase 3
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- Mercy Hospital Saint Louis, St Louis
- et 3 autres
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Recrutement en coursPhase 3
- Washington University School of Medicine, St Louis
- Mercy Hospital South, St Louis
- Siteman Cancer Center-South County, St Louis
- et 4 autres
Implementation and Effectiveness of the BJC-Pink and Pearl Project on Lung Cancer Screening
Recrutement en coursÉtude observationnelleVolontaires sains bienvenus
- Barnes-Jewish Hospital West County, Creve Coeur · à 12 mi
Evaluating the Implementation and Effectiveness of the Pink and Pearl Campaign on Lung Cancer Screening at Christian Hospital
Recrutement en coursVolontaires sains bienvenus
- Barnes-Jewish Christian Hospital, St Louis
IDOV-Immune for Advanced Solid Tumors
Recrutement en coursPhase 1
- Washington University School of Medicine, St Louis
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
Recrutement en coursPhase 1/2
- Washington University School of Medicine (Siteman Cancer Center), St Louis
CARE Tool Study Aim 3
Recrutement en cours
- Washington University School of Medicine, St Louis
- Alton Memorial Hospital, Alton · à 18 mi
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Recrutement en coursPhase 1/2
- Washington University, St Louis
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Recrutement en coursPhase 1
- Research Site, St Louis
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Recrutement en coursPhase 2
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- Mercy Hospital Saint Louis, St Louis
- et 2 autres
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Recrutement en coursPhase 1/2
- Washington University Infusion Center Pharmacy, St Louis
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Recrutement en coursPhase 2/3
- Washington University School of Medicine, St Louis
- Mercy Hospital South, St Louis
- Siteman Cancer Center-South County, St Louis
- et 7 autres
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Recrutement en coursPhase 2
- Washington University School of Medicine, St Louis
- Mercy Hospital South, St Louis
- Siteman Cancer Center-South County, St Louis
- et 4 autres
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Recrutement en coursPhase 1/2
- Washington University School of Medicine, St Louis
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Recrutement en coursÉtude observationnelleVolontaires sains bienvenus
- Washington University School of Medicine, St Louis
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
Recrutement en coursÉtude observationnelle
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- BJC Outpatient Center at Sunset Hills, Sunset Hills · à 13 mi
- et 3 autres
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recrutement en coursÉtude observationnelle
- Massive Bio SYNERGY-AI site, St Louis
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Recrutement en coursPhase 1/2
- Washington University, St Louis
Essais pour Cancer du poumon dans d'autres villes
- Houston, TX78 études
- Boston, MA62 études
- New York City, NY60 études
- Los Angeles, CA45 études
- Arlington, VA41 études
- Washington, DC41 études
- Chicago, IL41 études
- Baltimore, MD40 études
- Nashville, TN40 études
- Columbus, OH37 études
- Philadelphia, PA36 études
- Seattle, WA33 études
Autres études à St. Louis
- Cancer du poumon non à petites cellules73 études
- Cancer du sein64 études
- Cancer métastatique54 études
- Cancer colorectal50 études
- Cancer (tous types)46 études
- Cancer de la prostate46 études
- Cancer de l'ovaire38 études
- Cancer du pancréas33 études
- Cancer de l'endomètre29 études
- Carcinome épidermoïde de la tête et du cou28 études
- Insuffisance cardiaque26 études
- Obésité25 études
Source : ClinicalTrials.gov, données récupérées le 6 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.